Targeting Bacteria within Us to Diminish Infection and Autoimmunity

Samuel E. Weinberg; Navdeep S. Chandel

doi:10.1016/j.immuni.2020.12.006

Targeting Bacteria within Us to Diminish Infection and Autoimmunity

Samuel E. Weinberg, Navdeep S. Chandel^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Antibiotics improve clinical outcomes independent of their antibacterial effects. In this issue of Immunity, Almeida et al. and Colaço et al. demonstrate that antibiotic impairment of mitochondrial ribosomes modulates both T-cell-dependent inflammation and host tolerance to infection.

Original language	English (US)
Pages (from-to)	1-3
Number of pages	3
Journal	Immunity
Volume	54
Issue number	1
DOIs	https://doi.org/10.1016/j.immuni.2020.12.006
State	Published - Jan 12 2021

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.immuni.2020.12.006

Cite this

@article{203431c1a9bf4d37a66fc6f6f39e36d8,

title = "Targeting Bacteria within Us to Diminish Infection and Autoimmunity",

abstract = "Antibiotics improve clinical outcomes independent of their antibacterial effects. In this issue of Immunity, Almeida et al. and Cola{\c c}o et al. demonstrate that antibiotic impairment of mitochondrial ribosomes modulates both T-cell-dependent inflammation and host tolerance to infection.",

author = "Weinberg, {Samuel E.} and Chandel, {Navdeep S.}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2021",

month = jan,

day = "12",

doi = "10.1016/j.immuni.2020.12.006",

language = "English (US)",

volume = "54",

pages = "1--3",

journal = "Immunity",

issn = "1074-7613",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - Targeting Bacteria within Us to Diminish Infection and Autoimmunity

AU - Weinberg, Samuel E.

AU - Chandel, Navdeep S.

PY - 2021/1/12

Y1 - 2021/1/12

N2 - Antibiotics improve clinical outcomes independent of their antibacterial effects. In this issue of Immunity, Almeida et al. and Colaço et al. demonstrate that antibiotic impairment of mitochondrial ribosomes modulates both T-cell-dependent inflammation and host tolerance to infection.

AB - Antibiotics improve clinical outcomes independent of their antibacterial effects. In this issue of Immunity, Almeida et al. and Colaço et al. demonstrate that antibiotic impairment of mitochondrial ribosomes modulates both T-cell-dependent inflammation and host tolerance to infection.

UR - http://www.scopus.com/inward/record.url?scp=85098942002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098942002&partnerID=8YFLogxK

U2 - 10.1016/j.immuni.2020.12.006

DO - 10.1016/j.immuni.2020.12.006

M3 - Article

C2 - 33440134

AN - SCOPUS:85098942002

SN - 1074-7613

VL - 54

SP - 1

EP - 3

JO - Immunity

JF - Immunity

IS - 1

ER -

Targeting Bacteria within Us to Diminish Infection and Autoimmunity

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this